Research

Current position:Home > Research > R & D CenterR & D Center

(1) Qianhong International Incubator Project. (National "Twelfth Five-Year Plan" Project)

(2) Changzhou Biopharmaceutical Engineering Technology Center Co., Ltd.: with registered capital of 300,000 yuan. CQ holds 70% equity interest. Business scope includes technical services of genetic engineering, enzyme engineering, biological engineering, medicine, pesticides, and chemical intermediates.

(3) Changzhou Qianhong Universal Cell Engineering Institute Co., Ltd: with registered capital of 300,000 yuan. CQ holds 90% equity interest. Business scope includes technical development, transfer and consulting of human embryonic stem cells, human regenerated tissues with medical value, human embryonic totipotent stem cells, regeneration of human organs and tissues and the above derivative products.

(4) Jiangsu Zonghong Biological Engineering and Pharmaceutical Research Institute Co., Ltd.: with registered capital of 9,800,000 US dollars.CQ holds 59% equity interest. Business scope includes research and development, technology transfer, technical consulting and technical services of biopharmaceutical products and intermediates, biomedical reagents, in vitro diagnostic reagents, nutritional health products; the research and sale of biopharmaceutical and personalized medicine and clinical diagnostic system software.

Copyright © 2014 Changzhou Qianhong Bio-pharma Co.,ltd. All Rights Reserved.    Designed by  Zhonghuan Internet